Low and high-dose intradermal infection with Leishmania major and Leishmania amazonensis in C57BL/6 mice

Memorias do Instituto Oswaldo Cruz

Volumn 105, Issue 6, 2010, Pages 736-745

  Côrtes, Denise Fonseca ^a   Carneiro, Matheus Batista Heitor ^a   Santos, Liliane Martins ^a   De Oliveira Souza, Talita Correia ^a   Maioli, Tatiane Uceli ^a   Duz, Ana Luiza C ^b   Ramos Jorge, Maria Letícia ^a   Afonso, Luis Carlos Crocco ^c   Carneiro, Claudia ^b   Vieira, Leda Quercia ^a,c  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Escola de Farmacia   (Brazil)

^c FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

Cytokines; Infection; L. amazonensis; L. major; Leishmania

Indexed keywords

LEISHMANIA AMAZONENSIS; LEISHMANIA MAJOR; MUS;

EID: 77958085087     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762010000600002     Document Type: Article

References (40)

1. Afonso LC, Scott P 1993. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect Immun 61: 2952-2959.
2. Belkaid Y, Mendez S, Lira R, Kadambi N, Milon G, Sacks D 2000. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol 165: 969-977.
3. Corraliza IM, Campo ML, Soler G, Modolell M 1994. Determination of arginase activity in macrophages: a micromethod. J Immunol Methods 174: 231-235.
4. Courret N, Lang T, Milon G, Antoine JC 2003. Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice. Int J Parasitol 33: 1373-1383.
5. Courret N, Prina E, Mougneau E, Saraiva EM, Sacks DL, Glaichenhaus N, Antoine JC 1999. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites. Eur J Immunol 29: 762-773.
6. da Costa CA, Afonso LC, Toledo VP, Guimaraes TM, Nascimento E, Tavares CA, Mayrink W 1992. Immune responses and protection induced in mice by an industrialized vaccine against American cutaneous leishmaniasis. Parassitologia 34: 45-51.
7. Da Silva RP, Hall BF, Joiner KA, Sacks DL 1989. CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J Immunol 143: 617-622.
8. Felizardo TC, Toma LS, Borges NB, Lima GM, Abrahamsohn IA 2007. Leishmania (Leishmania) amazonensis infection and dissemination in mice inoculated with stationary-phase or with purified metacyclic promastigotes. Parasitology 134: 1699-1707.
9. Gomes IN, Calabrich AF, Tavares R da S, Wietzerbin J, de Freitas LA, Veras PS 2003. Differential properties of CBA/J mono-mononuclear phagocytes recovered from an inflammatory site and probed with two different species of Leishmania. Microbes Infect 5: 251-260.
10. González-Lombana CZ, Santiago HC, Macedo JP, Seixas VA, Russo RC, Tafuri WL, Afonso LC, Vieira LQ 2008. Early infection with Leishmania major restrains pathogenic response to Leishmania amazonensis and parasite growth. Acta Trop 106: 27-38.
11. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR 1982. Analysis of nitrate, nitrite and [15N]nitrate in biological fluids. Anal Biochem 126: 131-138.
12. Hernández Mx, Barçante TA, Vilela L, Tafuri WL, Afonso LC, Vieira LQ 2006. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40. Immunol Lett 105: 38-47.
13. Hernández Sanabria Mx, Afonso LC, Golgher D, Tafuri WL, Vieira LQ 2007. CD8+ T cells are not required for vaccine-induced immunity against Leishmania amazonensis in IL-12/23P40(-/-) C57BL/6 mice. Microbes Infect 9: 1124-1134.
14. Ji J, Sun J, Soong L 2003. Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect Immun 71: 4278-4288.
15. Jones DE, Ackermann MR, Wille U, Hunter CA, Scott P 2002. Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. Infect Immun 70: 2151-2158.
16. Killick-Kendrick R 1990. The life-cycle of Leishmania in the sandfly with special reference to the form infective to the vertebrate host. Ann Parasitol Hum Comp 65 (Suppl. 1): 37-42.
17. Lainson R, Shaw JJ, Silveira FT 1987. Dermal and visceral leishmaniasis and their causative agents. Trans R Soc Trop Med Hyg 81: 702-703.
18. Lattime EC, Stoppacciaro A, Stutman O 1988. Limiting dilution analysis of TNF producing cells in C3H/HeJ mice. J Immunol 141: 3422-3428.
19. Lemos de Souza V, Ascenção Souza J, Correia Silva TM, Sampaio Tavares Veras P, Rodrigues de-Freitas LA 2000. Different Leishmania species determine distinct profiles of immune and histopathological responses in CBA mice. Microbes Infect 2: 1807-1815.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
21. Lynn MA, McMaster WR 2008. Leishmania: conserved evolution-diverse diseases. Trends Parasitol 24: 103-105.
22. Mortatti RC, Henriques A 1990. Experimental cutaneous leishmaniasis by Leishmania amazonensis: course of fast-growth infection in the mouse ear. Parasitol Res 76: 729-730.
23. Mosser DM, Springer TA, Diamond MS 1992. Leishmania promastigotes require opsonic complement to bind to the human leukocyte integrin Mac-1 (CD11b/CD18). J Cell Biol 116: 511-520.
24. Mosser DM, Vlassara H, Edelson PJ, Cerami A 1987. Leishmania promastigotes are recognized by the macrophage receptor for advanced glycosylation endproducts. J Exp Med 165: 140-145.
25. Norsworthy NB, Sun J, Elnaiem D, Lanzaro G, Soong L 2004. Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production. Infect Immun 72: 1240-1247.
26. Oliveira MA, Santiago HC, Lisboa CR, Ceravollo IP, Trinchieri G, Gazzinelli RT, Vieira LQ 2000. Leishmania sp.: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis. Exp Parasitol 95: 96-105.
27. Oliveira MR, Tafuri WL, Afonso LC, Oliveira MA, Nicoli JR, Vieira EC, Scott P, Melo MN, Vieira LQ 2005. Germ-free mice pro-produce high levels of interferon-gamma in response to infection with Leishmania major but fail to heal lesions. Parasitology 131: 477-488.
28. Pinheiro RO, Rossi-Bergmann B 2007. Interferon-gamma is required for the late but not early control of Leishmania amazonensis infection in C57Bl/6 mice. Mem Inst Oswaldo Cruz 102: 79-82.
29. Qi H, Ji J, Wanasen N, Soong L 2004. Enhanced replication of Leishmania amazonensis amastigotes in gamma interferon-stimulated murine macrophages: implications for the pathogenesis of cutaneous leishmaniasis. Infect Immun 72: 988-995.
30. Santiago HC, Braga Pires MF, Souza DG, Roffê E, Côrtes DF, Tafuri WL, Teixeira MM, Vieira LQ 2006. Platelet activating factor receptor-deficient mice present delayed interferon-gamma upregulation and high susceptibility to Leishmania amazonensis infection. Microbes Infect 8: 2569-2577.
31. Santiago HC, Oliveira MA, Bambirra EA, Faria AM, Afonso LC, Vieira LQ, Gazzinelli RT 1999. Coinfection with Toxoplasma gondii inhibits antigen-specific Th2 immune responses, tissue inflammation and parasitism in BALB/c mice infected with Leishmania major. Infect Immun 67: 4939-4944.
32. Santiago HC, Oliveira CF, Santiago L, Ferraz FO, de Souza DG, de-Freitas LA, Afonso LC, Teixeira MM, Gazzinelli RT, Vieira LQ 2004. Involvement of the chemokine RANTES (CCL5) in resis-resistance to experimental infection with Leishmania major. Infect Immun 72: 4918-4923.
33. Saraiva EM, Andrade AF, Pereira ME 1986. Cell surface carbohy-carbohydrate of Leishmania mexicana amazonensis: differences between infective and non-infective forms. Eur J Cell Biol 40: 219-225.
34. Saraiva EM, Pinto-da-Silva LH, Wanderley JL, Bonomo AC, Barcinski MA, Moreira ME 2005. Flow cytometric assessment of Leishmania spp metacyclic differentiation: validation by morphological features and specific markers. Exp Parasitol 110: 39-47.
35. Scott P 1989. The role of Th1 and Th2 cells in experimental cutaneous leishmaniasis. Exp Parasitol 68: 369-372.
36. Soong L, xu JC, Grewal IS, Kima P, Sun J, Longley BJ Jr, Ruddle NH, McMahon-Pratt D, Flavell RA 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4: 263-273.
37. Späth GF, Beverley SM 2001. A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp Parasitol 99: 97-103.
38. Tuon FF, Neto VA, Amato VS 2008. Leishmania: origin, evolution and future since the Precambrian. FEMS Immunol Med Microbiol 54: 158-166.
39. Vanloubbeeck Y, Jones DE 2004. Protection of C3HeB/FeJ mice against Leishmania amazonensis challenge after previous Leishmania major infection. Am J Trop Med Hyg 71: 407-411.
40. Weigle K, Saravia NG 1996. Natural history, clinical evolution and the host-parasite interaction in New World cutaneous leishmaniasis. Clin Dermatol 14: 433-450.